IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bain Capital Life Sciences Investors, LLC

Q2 2019 Holdings

Filed 2019-08-14 | 5 holdings | $196.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$115.5K7,330,23758.6%
Replimune Group Inc(REPL)COM76029N106$41.6K2,838,96821.1%
Marinus Pharmaceuticals IncCOM56854Q101$20.9K5,042,73510.6%
Solid Biosciences IncCOM83422E105$11.4K1,989,4445.8%
Aptinyx IncCOM03836N103$7.4K2,225,0923.8%